Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis

Hemodialysis International

Volumn 20, Issue 1, 2016, Pages 68-77

  Plesner, Louis L ^a,b   Warming, Peder E ^a,b   Nielsen, Ture L ^b   Dalsgaard, Morten ^a   Schou, Morten ^a   Høst, Ulla ^a   Rydahl, Casper ^a   Brandi, Lisbet ^b   Køber, Lars ^c   Vestbo, Jørgen ^a,d   Iversen, Kasper ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Comorbidity; End stage kidney disease; Hemodialysis; Lung congestion; Spirometry

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; END STAGE RENAL DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPIROMETRY; ADVERSE EFFECTS; CHRONIC KIDNEY FAILURE; COMORBIDITY; COMPLICATION; HEMODIALYSIS; MIDDLE AGED; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; COMORBIDITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL DIALYSIS; SPIROMETRY;

EID: 84956590774     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12342     Document Type: Article

References (44)

1. Palamidas AF, Gennimata S-A, Karakontaki F, etal. Impact of hemodialysis on dyspnea and lung function in end stage kidney disease patients. Biomed Res Int. 2014; 2014:212751.
2. Prezant DJ. Effect of uremia and its treatment on pulmonary function. Lung. 1990; 168:1-14.
3. Bush A, Gabriel R. The lungs in uraemia: a review. J R Soc Med. 1985; 78:849-855.
4. Kent BD, Eltayeb EE, Woodman A, Mutwali A, Nguyen HT, Stack AG. The impact of chronic obstructive pulmonary disease and smoking on mortality and kidney transplantation in end-stage kidney disease. Am J Nephrol. 2012; 36:287-295.
5. Van Gestel YRBM, Chonchol M, Hoeks SE, etal. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant. 2009; 24:2763-2767.
6. Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2011; 17:S21-S28.
7. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V. Chronic renal failure: a neglected comorbidity of COPD. Chest. 2010; 137:831-837.
8. Sin DD. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003; 107:1514-1519.
9. Lang SM, Becker A, Fischer R, Huber RM, Schiffl H. Acute effects of hemodialysis on lung function in patients with end-stage renal disease. Wien Klin Wochenschr. 2006; 118:108-113.
10. Karacan Ö, Tutal E, Uyar M, Eyüboğlu FÖ, Sezer S, Özdemir FN. Pulmonary function in uremic patients on long-term hemodialysis. Ren Fail. 2004; 26:273-278.
11. Alves J, Hespanhol V, Fernandes J, Marques EJA. Improvement in pulmonary function caused be hemodialysis. Correlation with the other parameters usually obtained to evaluate the dialytic efficiency. Acta Med Port. 1989; 4:195-198.
12. Kovačević P, Stanetic M, Rajkovaca Z. Changes in spirometry over time in uraemic patients receiving longterm haemodialysis therapy. Pneumologia. 2011; 60:36-39.
13. Navari K, Farshidi H, Pour-Reza-Gholi F, etal. Spirometry parameters in patients undergoing hemodialysis with bicarbonate and acetate dialysates. Iran J Kidney Dis. 2008; 2:149-153.
14. Vestbo J, Hurd SS, Agusti AG, etal. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014. Available from: http://www.goldcopd.org/ (accessed date: June 19, 2014).
15. Roca J, Burgos F, Sunyer J, etal. References values for forced spirometry. Eur Respir J. 1998; 11:1354-1362.
16. Pellegrino R, Viegi G, Brusasco V, etal. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26:948-968.
17. Løkke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M, Lange P. New Danish reference values for spirometry. Clin Respir J. 2012; May 2014 [Epub ahead of print].
18. Ifudu O, Mayers J, Matthew J, Tan CC, Cambridge A, Friedman EA. Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA. 1994; 271:29-33.
19. Danish Nephrology Registry (DNR) Annual Report. 2013. Available from: http://www.nephrology.dk (accessed date: June 14, 2015).
20. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci V. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14:3270-3277.
21. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 2005; 60:842-847.
22. Iversen KK, Kjaergaard J, Akkan D, etal. Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med. 2008; 264:361-369.
23. Nascimento MM, Qureshi AR, Stenvinkel P, etal. Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. Nephrol Dial Transplant. 2004; 19:1823-1828.
24. Orth SR, Ritz E. The renal risks of smoking: an update. Curr Opin Nephrol Hypertens. 2002; 11:483-488.
25. Pawlak K, Ulazka B, Mysliwiec M, Pawlak D. Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Transl Res. 2012; 160:346-354.
26. Okyay GU, Er RE, Tekbudak MY, etal. Novel inflammatory marker in dialysis patients: YKL-40. Ther Apher Dial. 2013; 17:193-201.
27. Sjöberg B, Qureshi AR, Anderstam B, Alvestrand A, Bárány P. Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation. Blood Purif. 2012; 34:290-297.
28. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009; 33:1165-1185.
29. Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008; 31:204-212.
30. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186:982-988.
31. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003; 21:347-360.
32. Razeghi E, Pazoki M, Ahmadi F, etal. Relation between pulmonary function and inflammatory biomarkers in hemodialysis patients. Ren Fail. 2012; 34:24-27.
33. Dimopoulou I, Tsintzas K, Tzelepis GE. Effects of severity of long-standing failure on pulmonary function congestive heart. Respir Med. 1998; 92:1321-1325.
34. Ravenscraft SA, Gross CR, Kubo SH, etal. Pulmonary function after successful heart transplantation. One year follow-up. Chest. 1993; 103:54-58.
35. Petermann W, Barth J, Entzian P. Heart failure and airway obstruction. Int J Cardiol. 1987; 17:207-209.
36. Ries A, Gregoratos G, Friedman P, Clausen J. Pulmonary function tests in the detection of left heart failure: correlation with pulmonary artery wedge pressure. Respiration. 1986; 49:241-250.
37. Hosenpud J, Stibolt T, Atwal K, Shelley D. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med. 1990; 88:493-496.
38. Apostolovic S, Jankovic-Tomasevic R, Salinger-Martinovic S, etal. Frequency and significance of unrecognized chronic obstructive pulmonary disease in elderly patients with stable heart failure. Aging Clin Exp Res. 2011; 23:337-342.
39. Çolak Y, Løkke A, Marott JL, Lange P, Vestbo J. Impact of diagnostic criteria on the prevalence of COPD. Clin Respir J. 2013; 7:297-303.
40. Rahgoshai R, Rahgoshai R, Khosraviani A, Nasiri AA, Solouki M. Acute effects of hemodialysis on pulmonary function in patients with end-stage renal disease. Iran J Kidney Dis. 2010; 4:214-217.
41. Kovelis D, Pitta F, Probst VS, etal. Pulmonary function and respiratory muscle strength in chronic renal failure patients on hemodialysis. J Bras Pneumol. 2008; 34:907-912.
42. Cury JL, Brunetto AF, Aydos RD. Negative effects of chronic kidney failure on lung function and functional capacity. Rev Bras Fisioter. 2010; 14:91-98.
43. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge SDM. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359:1543-1554.
44. Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356:775-789.